LMC Login | CPMC Login | My Games Account Login
Change Region: Asia | Europe | USA | UK | RoW
Register for Updates & Free Games Account
Complete the form below to register with us for updates. We will update you when new challenges and games are available to play.
First Name:
Surname:
Country:
Email:
Re-enter email:
If you would like a free PharmaSchool Games Account so you can record your weekly GCP Challenge Scores please check the box below and add a password:
Free Games Account:
Password:
Re-enter Password:
 
 
 
Weekly GCP Challenge

Answer the questions below and then click the button. The next page will mark your answers and show you how well you have done compared with the previous people who have taken the tests.


Challenge: ICH GCP - Informed Consent

Question Number 1:

What does ICH GCP Section 4.8 say about the factors that the investigator should comply with?

"In obtaining and documenting informed consent, the investigator should comply with the applicable regulatory requirements, and should adhere to GCP and to the ethical principles that.........."

A
are stated in the protocol
B
have their origin in the Declaration of Helsinki
C
are stated by the IRB/IEC
D
all of the above

Question Number 2:

What does ICH GCP state about the investigator or trial staff persuading subjects to take part in a trial?

"Neither the investigator, nor the trial staff, should ................... a subject to participate or to continue to participate in a trial"

A
persuade
B
force
C
coerce or unduly influence
D
use inappropriate methods to influence

Question Number 3:

What does ICH GCP state about the signing process of the informed consent by the subject or subject's legally acceptable representative?

"The written informed consent must be ............... by the subject or subject's legally acceptable representative"

A
Signed
B
Signed and dated
C
Signed and personally dated
D
Signed, personally dated and the name stated

Question Number 4:

In emergency situations when prior consent of the subject is not possible and the subject's legally acceptable representative is not available the enrolment of the subject should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC. What does ICH GCP state about the next stages of consent?

"The subject or subject's legally acceptable representative should be........"

A
informed as soon as possible
B
informed as soon as possible and consent to continue
C
informed as soon as possible and consent to continue and other consent as appropriate be requested
D
There is no reference to further consent

Question Number 5:

ICH GCP states what information and explanations should be provided to the subject prior to informed consent. Which of the following are included in this list?

1) The approximate number of subjects involved in the trial

2) The subject's responsibilities

3) That the trial involves research

4) The expected duration of the subject's participation in the trial

A
All of them
B
None of them
C
1 and 2 only
D
2 and 4 only

Sort the Challenges
GCP & Guidelines
Trial Design
Adverse Events
Monitoring
Statistics
Abbreviations
General
Show All
International Sites: USA Europe Asia Rest of World
PharmaSchool Ltd. Registered in England & Wales No: 05439862
t: +44 (0) 845 224 0891 f: +44 (0) 845 224 0873 e: info@pharmaschool.co.uk